Takeda Announces War Chest

Japanese drugmaker Takeda has announced that it will set aside a war chest of JPY1trn (US$8.4bn) for strategic acquisitions, as the company looks to move away from its focus on inorganic growth. BMI has long predicted such a move as Takeda suffers from a weak pipeline and has failed to adequately embrace the biotechnology boom. As a result, the company is now looking to buy itself out of trouble.

To read the full article, please choose one of the following options: